Activating anti-MDS immunity through restoration of the immune microenvironment

The Department of the Army Medical Command awarded a $744,224 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to activate anti-myelodysplastic syndrome immunity through restoration of the immune microenvironment.

The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and public health outcomes. This award will allow the grantee to investigate medical solutions for conditions like myelodysplastic syndrome, which can impact service members. The three-year period of performance indicates the grantee will conduct a comprehensive research program. The funding and program details suggest the grantee will develop new knowledge and therapies to restore immune function for diseases such as myelodysplastic syndrome.